Schulz-Utermoehl T[au] - Search Results

Year	Number of Results
1999	2
2000	3
2001	1
2005	1
2006	1
2010	2
2011	3
2012	6
2013	2
2016	1
2017	1
2019	1
2021	1
2022	0

1

Application of HepG2/C3A liver spheroids as a model system for genotoxicity studies.

Coltman NJ, Coke BA, Chatzi K, Shepherd EL, Lalor PF, Schulz-Utermoehl T, Hodges NJ. Coltman NJ, et al. Among authors: schulz utermoehl t. Toxicol Lett. 2021 Jul 1;345:34-45. doi: 10.1016/j.toxlet.2021.04.004. Epub 2021 Apr 15. Toxicol Lett. 2021. PMID: 33865918

2

Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia.

Li X, Payne DT, Ampolu B, Bland N, Brown JT, Dutton MJ, Fitton CA, Gulliver A, Hale L, Hamza D, Jones G, Lane R, Leach AG, Male L, Merisor EG, Morton MJ, Quy AS, Roberts R, Scarll R, Schulz-Utermoehl T, Stankovic T, Stevenson B, Fossey JS, Agathanggelou A. Li X, et al. Among authors: schulz utermoehl t. Medchemcomm. 2019 Aug 1;10(8):1379-1390. doi: 10.1039/c9md00297a. eCollection 2019 Aug 1. Medchemcomm. 2019. PMID: 32952998 Free PMC article.

3

Pharmacokinetics and metabolism of midazolam in chimeric mice with humanised livers.

Samuelsson K, Pickup K, Sarda S, Swales JG, Morikawa Y, Schulz-Utermoehl T, Hutchison M, Wilson ID. Samuelsson K, et al. Among authors: schulz utermoehl t. Xenobiotica. 2012 Nov;42(11):1128-37. doi: 10.3109/00498254.2012.689888. Epub 2012 May 30. Xenobiotica. 2012. PMID: 22642803

4

Characterisation and identification of the human N+-glucuronide metabolite of cediranib.

Lenz EM, Spear M, Drake C, Pollard CR, Ward M, Schulz-Utermoehl T, Harrison M. Lenz EM, et al. Among authors: schulz utermoehl t. J Pharm Biomed Anal. 2010 Nov 2;53(3):526-36. doi: 10.1016/j.jpba.2010.03.023. Epub 2010 Mar 27. J Pharm Biomed Anal. 2010. PMID: 20409669

5

Acute liver effects, disposition and metabolic fate of [¹⁴C]-fenclozic acid following oral administration to normal and bile-cannulated male C57BL/6J mice.

Pickup K, Martin S, Partridge EA, Jones HB, Wills J, Schulz-Utermoehl T, McCarthy A, Rodrigues A, Page C, Ratcliffe K, Sarda S, Wilson ID. Pickup K, et al. Among authors: schulz utermoehl t. Arch Toxicol. 2017 Jul;91(7):2643-2653. doi: 10.1007/s00204-016-1894-5. Epub 2016 Nov 28. Arch Toxicol. 2017. PMID: 27896398 Free PMC article.

6

In vitro exploration of potential mechanisms of toxicity of the human hepatotoxic drug fenclozic acid.

Rodrigues AV, Rollison HE, Martin S, Sarda S, Schulz-Utermoehl T, Stahl S, Gustafsson F, Eakins J, Kenna JG, Wilson ID. Rodrigues AV, et al. Among authors: schulz utermoehl t. Arch Toxicol. 2013 Aug;87(8):1569-79. doi: 10.1007/s00204-013-1056-y. Epub 2013 Apr 23. Arch Toxicol. 2013. PMID: 23609606

7

Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized livers.

Schulz-Utermoehl T, Sarda S, Foster JR, Jacobsen M, Kenna JG, Morikawa Y, Salmu J, Gross G, Wilson ID. Schulz-Utermoehl T, et al. Xenobiotica. 2012 Jun;42(6):503-17. doi: 10.3109/00498254.2011.640716. Epub 2011 Dec 27. Xenobiotica. 2012. PMID: 22201515

8

A quantitative high-throughput trapping assay as a measurement of potential for bioactivation.

Meneses-Lorente G, Sakatis MZ, Schulz-Utermoehl T, De Nardi C, Watt AP. Meneses-Lorente G, et al. Among authors: schulz utermoehl t. Anal Biochem. 2006 Apr 15;351(2):266-72. doi: 10.1016/j.ab.2006.01.016. Epub 2006 Jan 30. Anal Biochem. 2006. PMID: 16473319

9

Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouse.

Foster JR, Jacobsen M, Kenna G, Schulz-Utermoehl T, Morikawa Y, Salmu J, Wilson ID. Foster JR, et al. Among authors: schulz utermoehl t. Toxicol Pathol. 2012 Dec;40(8):1106-16. doi: 10.1177/0192623312447542. Epub 2012 Jun 6. Toxicol Pathol. 2012. PMID: 22673116

10

A semi-automated method for measuring the potential for protein covalent binding in drug discovery.

Day SH, Mao A, White R, Schulz-Utermoehl T, Miller R, Beconi MG. Day SH, et al. Among authors: schulz utermoehl t. J Pharmacol Toxicol Methods. 2005 Sep-Oct;52(2):278-85. doi: 10.1016/j.vascn.2004.11.006. J Pharmacol Toxicol Methods. 2005. PMID: 16125627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results